C12Y 207/08001
Ethanolaminephosphotransferase
Official title: Ethanolaminephosphotransferase (2.7.8.1)
C12Y207/08001 (Ethanolaminephosphotransferase) appears on 5 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 5
- Assignees
- 2
- Inventors
- 5
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered strains with reduced byproduct formation17 Feb 2026US 12,553,071 B2Dsm IP Assets B.V.
- Methods for treating cardiac conditions16 May 2023US 11,648,281 B2MiMedx Group, Inc.
- Placental tissue composition for for treating cardiac tissue damage11 May 2021US 11,000,553 B2MiMedx Group, Inc.
- Methods for treating cardiac conditions30 Oct 2018US 10,111,910 B2MiMedx Group, Inc.
- Methods for treating cardiac conditions30 May 2017US 9,662,355 B2MiMedx Group, Inc.
- Genetically engineered strains with reduced byproduct formation12 Dec 2024US 2024/0409972 A1Dsm IP Assets B.V.
- Methods for treating cardiac conditions6 May 2021US 2021/0128637 A1MiMedx Group, Inc.
- Methods for treating cardiac conditions3 Jan 2019US 2019/0000890 A1MiMedx Group, Inc.
- Methods for treating cardiac conditions27 Aug 2015US 2015/0238540 A1MiMedx Group, Inc.
- Methods for treating cardiac conditions15 Jan 2015US 2015/0017255 A1MiMedx Group, Inc.
Most cited
By later US patents